Search
for
Sort by
Research 31–60 of 1000+
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- 691 Topical curcumin promotes induction of the murine hair cycle
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Alopecia areata: current concepts
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Single-cell sequencing combined with spatial transcriptomics reveals the characteristics of follicle-targeted inflammation patterns in primary cicatricial alopecia
- Jak inhibitors in the treatment of alopecia areata - a literature review
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Topical metformin as a novel therapy for alopecia areata due to its immunologic effects
- Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: A case report
- An Overview about Alopecia Areata Etiopathogenesis, Diagnosis, and Management: Review Article
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Two Birds that Exclude Each Other: The Renbök Phenomenon
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- Diagnostic Challenges and Treatment Strategies in Neutrophilic Cicatricial Alopecias: A Narrative Review from Conventional Therapies to New Therapeutic Targets
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- BH17 Bridging the gap: identifying dual-targeting therapies for patients with alopecia areata and coexisting immune-mediated inflammatory diseases
- Baricitinib in the Management of Coexisting Alopecia Areata and Atopic Dermatitis: A Case Report
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia
- 59 Scarring alopecia is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege
- Successful treatment of coexisting alopecia areata and hidradenitis suppurativa with upadacitinib
- Psychophysiological Mechanisms of Stress Impact on Hair Loss Processes
- Treatment of alopecia areata with JAK inhibitors